Social factors affecting interest in participating in a prostate cancer chemoprevention trial

Journal of Cancer Education

Volumn 14, Issue 2, 1999, Pages 88-92

  Lee, Misa M ^a   Chamberlain, Robert M ^e   Catchatourian, Rose ^a   Hiang, J ^b   Kopnick, Mitchell ^a   Ray, Paul ^c   Vijayakumar, Srinivasan ^a,d  

^a MICHAEL REESE HOSPITAL   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c Jr Hospital of Cook County   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

^e University of Illinois Hospitals ^*

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATTITUDE; CANCER PREVENTION; CANCER SCREENING; ETHNIC DIFFERENCE; FEMALE; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HUMAN; HUMAN EXPERIMENT; MALE; MARRIAGE; NORMAL HUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSTATE CANCER; SOCIAL ASPECT;

AFRICAN AMERICANS; ANALYSIS OF VARIANCE; ANTICARCINOGENIC AGENTS; CHEMOPREVENTION; CLINICAL TRIALS; DATA COLLECTION; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT PARTICIPATION; PROSTATIC NEOPLASMS; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 0033054784     PISSN: 08858195     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Landis SH, Murray T, Bolder S, Wingo PA. Cancer statistics, 1998. CA Cancer J Clin. 1998;48:6-29.
2. Parker SL, Davis KJ, Wingo PA, Ries LA, Heath CW Jr. Cancer statistics by race and ethnicity. CA Cancer J Clin. 1998;48:31-48.
3. Rose DP, Boyar AP, Wynder EL. International comparison for mortality rates for cancer of the breast, ovary, prostate and colon, and per capita food consumption. Cancer. 1986;58:2363-71.
4. Thompson IM, Brawer MK, Miller GJ, Crawford ED. SWOG-9217: chemoprevention of prostate cancer with Finasteride (Proscar) Phase III (protocol guideline).
5. Hunninghake DB, Darby CA, Probstfield JL. Recruitment experience in clinical trials: literature summary and annotated bibliography. Controlled Clinical Trials. 1987;8(suppl): 6S-30S.
6. Svensson CK. Representation of American blacks in clinical trials of new drugs. JAMA. 1989;261:263-5.
7. Freeman HP. Cancer in the economically disadvantaged. Cancer. 1989:64(1 suppl): 325-34.
8. American Cancer Society. Report to the nation: cancer in the poor. Atlanta, GA: American Cancer Society, 1989.
9. Ostfeld AM, Shekelle RB, Tufo HM, Wieland AM, Kilbridge JA, Drori J. Cardiovascular and cerebrovascular disease in an elderly poor urban population. Am J Public Health. 1971;61:19-29.
10. National Cancer Institute Annual Cancer Statistics Review. Washington, DC: Government Printing Office, U.S. Department of Health and Human Services Publication No. PHS, NIH 88-2789, 1987.
11. Michielutte R, Diseker RA. Racial differences in knowledge of cancer: a pilot study. Sox Sci Med. 1982;16:245-52
12. Jepson C, Kessler LG, Portnoy B, Gibbs T. Black-white differences in cancer prevention knowledge and behavior. Am J Public Health. 1991;81:501-4.
13. Price JH, Desmond SH, Wallace M, Smith d, Stewart TW. Black American's perception on cancer. J Natl Med Assoc. 1988;80:1297-304.
14. Bloom JR, Hayes WA, Saunders F, Flatt S. Cancer awareness and secondary preventive practices in black Americans: implications for intervention. Family Community Health. 1987;10:19-30.